Metropolitan Life Insurance CO Revolution Medicines, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$26.56 - $33.55 $22,549 - $28,483	-849 Reduced 10.38%	7,328 $236,000
Q4 2023 Feb 14, 2024	BUY	$18.35 - $34.12 $42,847 - $79,670	2,335 Added 39.97%	8,177 $234,000
Q3 2023 Nov 14, 2023	BUY	$25.17 - $35.05 $7,601 - $10,585	302 Added 5.45%	5,842 $161,000
Q2 2023 Aug 10, 2023	BUY	$20.28 - $27.0 $18,049 - $24,030	890 Added 19.14%	5,540 $148,000
Q1 2023 May 15, 2023	SELL	$20.76 - $30.09 $228 - $330	-11 Reduced 0.24%	4,650 $100,000
Q4 2022 Jun 14, 2023	BUY	$17.68 - $25.53 $194 - $280	11 Added 0.24%	4,661 $111 Million
Q4 2022 Mar 30, 2023	BUY	$17.68 - $25.53 $3,182 - $4,595	180 Added 4.02%	4,661 $111,000
Q4 2022 Feb 15, 2023	BUY	$17.68 - $25.53 $3,182 - $4,595	180 Added 4.02%	4,661 $111,000
Q3 2022 Jun 14, 2023	SELL	$17.46 - $26.0 $2,950 - $4,394	-169 Reduced 3.63%	4,481 $88.4 Million
Q3 2022 Mar 30, 2023	BUY	$17.46 - $26.0 $10,056 - $14,976	576 Added 14.75%	4,481 $88,000
Q3 2022 Nov 14, 2022	BUY	$17.46 - $26.0 $10,056 - $14,976	576 Added 14.75%	4,481 $88,000
Q2 2022 Jun 20, 2023	SELL	$14.54 - $27.17 $10,832 - $20,241	-745 Reduced 16.02%	3,905 $76,000
Q1 2022 Jun 20, 2023	SELL	$17.31 - $26.4 $12,895 - $19,668	-745 Reduced 16.02%	3,905 $99,000
Q1 2022 Mar 30, 2023	SELL	$17.31 - $26.4 $218,850 - $333,775	-12,643 Reduced 76.4%	3,905 $99,000
Q1 2022 May 12, 2022	SELL	$17.31 - $26.4 $218,850 - $333,775	-12,643 Reduced 76.4%	3,905 $100,000
Q4 2021 Jun 21, 2023	BUY	$24.35 - $33.7 $289,716 - $400,962	11,898 Added 255.87%	16,548 $416,000
Q3 2021 Jun 21, 2023	BUY	$23.95 - $33.41 $284,957 - $397,512	11,898 Added 255.87%	16,548 $455,000
Q2 2021 Jun 21, 2023	BUY	$29.0 - $47.44 $345,042 - $564,441	11,898 Added 255.87%	16,548 $525,000
Q2 2021 Mar 30, 2023	BUY	$29.0 - $47.44 $157,731 - $258,026	5,439 Added 48.96%	16,548 $525,000
Q2 2021 Aug 16, 2021	BUY	$29.0 - $47.44 $479,573 - $784,515	16,537 Added 150336.36%	16,548 $525,000
Q1 2021 Jun 26, 2023	BUY	$37.21 - $54.43 $240,339 - $351,563	6,459 Added 138.9%	11,109 $510 Million
Q1 2021 Mar 30, 2023	SELL	$37.21 - $54.43 $12,167 - $17,798	-327 Reduced 2.86%	11,109 $509,000
Q1 2021 May 14, 2021	SELL	$37.21 - $54.43 $425,124 - $621,862	-11,425 Reduced 99.9%	11 $510,000
Q4 2020 Jun 22, 2023	BUY	$30.19 - $45.49 $204,869 - $308,695	6,786 Added 145.94%	11,436 $452,000
Q3 2020 Jun 26, 2023	BUY	$22.61 - $34.8 $153,431 - $236,152	6,786 Added 145.94%	11,436 $397,000
Q3 2020 Mar 30, 2023	BUY	$22.61 - $34.8 $146,444 - $225,399	6,477 Added 130.61%	11,436 $397,000
Q3 2020 Nov 13, 2020	BUY	$22.61 - $34.8 $146,444 - $225,399	6,477 Added 130.61%	11,436 $398,000
Q2 2020 Jun 26, 2023	BUY	$19.65 - $39.34 $6,071 - $12,156	309 Added 6.65%	4,959 $156,000
Q1 2020 Jul 12, 2023	BUY	$20.0 - $34.08 $6,180 - $10,530	309 Added 6.65%	4,959 $108,000
Q1 2020 Mar 30, 2023	BUY	$20.0 - $34.08 $5,960 - $10,155	298 Added 6.39%	4,959 $108,000
Q1 2020 May 15, 2020	BUY	$20.0 - $34.08 $99,180 - $169,002	4,959 New	4,959 $109,000

Others Institutions Holding RVMD

# of Institutions

266

Shares Held

161M

Call Options Held

260K

Put Options Held

620K

Vanguard Group Inc Valley Forge, PA

14.9M
Shares

$646 Million
0.01% of portfolio
Black Rock Inc. New York, NY

13.4M
Shares

$580 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

11.4M
Shares

$494 Million
0.09% of portfolio
Farallon Capital Management LLC San Francisco, CA

11.3M
Shares

$490 Million
2.58% of portfolio
Baker Bros. Advisors LP New York, NY

7.57M
Shares

$328 Million
3.67% of portfolio

View Full List

About Revolution Medicines, Inc.

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.8B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

More about RVMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account